Clinical Trial: Rapid Escalation Oral Immunotherapy to Achieve Remission in Children With Cashew Allergy

U.S., Oct. 10 -- ClinicalTrials.gov registry received information related to the study (NCT07868731) titled 'Rapid Escalation Oral Immunotherapy to Achieve Remission in Children With Cashew Allergy' on Oct. 05.

Brief Summary: Children with cashew allergy have no approved treatment and must rely on lifelong avoidance, which is stressful and often fails. Less than 10% outgrow their allergy. Cashew is a leading cause of severe reactions in young children. Oral immunotherapy (OIT) can induce remission in peanut allergy, allowing children to eat peanut safely, but this has not been tested for cashew. This study will assess whether cashew OIT can safely achieve remission and improve quality of life.

Study Start Date: Oct., 2026

Study Type: INT...